Please login to the form below

Not currently logged in
Email:
Password:

Enstilar

This page shows the latest Enstilar news and features for those working in and with pharma, biotech and healthcare.

Leo Pharma’s Enstilar approved by FDA

Leo Pharma’s Enstilar approved by FDA

Topical psoriasistreatment given the green light. The FDA has approved Leo Pharma's Enstilar foam for the treatment of plaque psoriasis. ... Enstilar (calcipotriene/betamethasone dipropionate) is a once-daily, alcohol free foam formulation in a

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics